{"id":"https://openalex.org/A5041670546","orcid":null,"observed_orcids":[],"display_name":"Christopher W. Allard","raw_author_names":["Christopher W. Allard"],"full_name":"Christopher W. Allard","works_count":4,"cited_by_count":122,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":3,"i10_index":3},"ids":{"openalex":"https://openalex.org/A5041670546","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210091812","ror":"https://ror.org/00gtmwv55","display_name":"Bristol-Myers Squibb (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]},"years":[2021,2020,2019]}],"last_known_institutions":[{"id":"https://openalex.org/I4210091812","ror":"https://ror.org/00gtmwv55","display_name":"Bristol-Myers Squibb (United States)","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","count":4,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","count":3,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","count":2,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":1,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","count":1,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","value":1.59e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","value":1.12e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","value":7.1e-06,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","value":2.5e-06,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"14430832","wikidata":"https://www.wikidata.org/wiki/Q412550","display_name":"Integrase","score":0.959567666053772},{"id":"55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","score":0.33846309781074524},{"id":"86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","score":0.31884026527404785},{"id":"104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","score":0.12019824981689453},{"id":"142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","score":0.09785634279251099}],"counts_by_year":[{"year":2019,"works_count":2,"oa_works_count":0,"cited_by_count":5},{"year":2020,"works_count":1,"oa_works_count":0,"cited_by_count":7},{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":12},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":23},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":8},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":25},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":20},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":22}],"display_name_alternatives":["Christopher W. Allard"],"block_key":"c allard","works_api_url":"https://api.openalex.org/works?filter=author.id:A5041670546","awards_count":0,"updated_date":"2026-11-07T12:08:38","created_date":"2019-01-11T00:00:00"}